COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,757 Articles (22,502 medRxiv, 8,255 bioRxiv)

Most recent first Previous |  Page 525: Articles 5241-5250  | Next

Clinical Evaluation of the GeneXpert(R) Xpert(R) Xpress SARS-CoV-2/Flu/RSV PLUS Combination Test
Johnson, G., Gregorchuk, B. S. J., Zubrzycki, A., Kolsun, K., Meyers, A. F. A., Sandstorm, P. A., Becker, M. G.
10.1101/2022.11.07.22281957 — Posted: 2022-11-14
COVID Seq as Laboratory Developed Test (LDT) for diagnosis of SARS-CoV-2 Variants of Concern (VOC)
Carpenter, R. E., Tamrakar, V. K., Brown, E., Almas, S., Sharma, R.
10.1101/2022.11.11.22282032 — Posted: 2022-11-14
Conceptualising the Episodic Nature of Disability among Adults Living with Long COVID: A Qualitative Study
O'Brien, K., Brown, D. A., McDuff, K., St. Clair-Sullivan, N., Solomon, P., Chan Carusone, S., McCorkell, L., Wei, H., Goulding, S., O'Hara, M., Thomson, C., Roche, N., Stokes, R., Vera, J. H., Erlandson, K., Bergin, C., Robinson, L., Cheung, A. M., Torres, B., Avery, L., Bannan, C., Harding, R.
10.1101/2022.11.12.22282116 — Posted: 2022-11-14
Protection against infection with the Omicron BA.5 subvariant among people with previous SARS-CoV-2 infection - surveillance results from southern Sweden, June to August 2022
Kahn, F., Bonander, C., Moghaddassi, M., Bennet, L., Malmqvist, U., Inghammar, M., Bjork, J.
10.1101/2022.11.08.22282069 — Posted: 2022-11-14
Successful Detection of Delta and Omicron Variants of SARS-CoV-2 by Veterinary Diagnostic Laboratory Participants in an Interlaboratory Comparison Exercise
Deng, K., Nemser, S. M., Frost, K., Goodman, L. B., Ip, H. S., Killian, M. L., Ulaszek, J., Kiener, S., Kmet, M., Uhlig, S., Hettwer, K., Colson, B., Nichani, K., Schlierf, A., Tkachenko, A., Miller, M. R., Reddy, R., Tyson, G. H.
10.1101/2022.11.08.22282084 — Posted: 2022-11-14
Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label, randomized controlled trial (the EPCoT Study).
Fezzi, M., Antolini, L., Soria, A., Bisi, L., Iannuzzi, F., Sabbatini, F., Rossi, M., Limonta, S., Rugova, A., Columpsi, P., Squillace, N., Foresti, S., Pollastri, E., Valsecchi, M. G., Migliorino, G. M., Bonfanti, P., Lapadula, G.
10.1101/2022.11.12.22282252 — Posted: 2022-11-14
Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves
Doll, M. K., Waghmare, A., Heit, A., Levenson Shakoor, B., Kimball, L. E., Ozbek, N., Blazevic, R. L., Mose, L., Boonyaratanakornkit, J., Stevens-Ayers, T. L., Cornell, K., Sheppard, B. D., Hampson, E., Sharmin, F., Goodwin, B., Dan, J. M., Archie, T., O'Connor, T., Heckerman, D., Schmitz, F., Boeckh, M., Crotty, S.
10.1101/2022.11.13.22282222 — Posted: 2022-11-14
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
Ramos Benitez, M. J., Strich, J. R., Alehashemi, S., Stein, S., Rastegar, A., de Jesus, A. A., Bhuyan, F., Ramelli, S., Babyak, A., Perez-Valencia, L., Vannella, K. M., Grubbs, G., Khurana, S., Gross, R., Hadley, K., Liang, J., Mazur, S., Postnikova, E., Warner, S., Holbrook, M., Busch, L. M., Warner, B., Applefeld, W., Warner, S., Kadri, S. S., Davey, R. T., Goldbach-Mansky, R., Chertow, D. S.
10.1101/2022.11.08.22281846 — Posted: 2022-11-13
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Hackney, J. A., Shivram, H., Vander Heiden, J., Overall, C., Orozco, L., Gao, X., West, N., Qamra, A., Chang, D., Chakrabarti, A., Choy, D. F., Combes, A. J., Courau, T., Fragiadakis, G. K., Rao, A. A., Ray, A., Tsui, J., Hu, K., Kuhn, N. F., Krummel, M. F., Erle, D. J., Kangelaris, K., Sarma, A., Lyon, Z., Calfee, C. S., Woodruff, P. G., Ghale, R., Mick, E., Byrne, A., Zha, S., Langelier, C., Hendrickson, C. M., van der Wijst, M. G. P., Hartoularos, G. C., Grant, T., Bueno, R., Lee, D. S., Greenland, J. R., Sun, Y., Perez, R., Ogorodnikov, A., Ward, A., Ye, C. J., UCSF COMET Consortium, , Ramalingam, T., McBride, J. M., Cai, F., Teterina, A., Bao, M., Tsai, L., Rosas, I. O., Regev, A., Kapadia, S. B., Bauer, R. N., Rosenberger, C. M.
10.1101/2022.11.07.22282049 — Posted: 2022-11-13
SIR analytical model applied to 2020 Covid-19 data in Italy
Simeone, R.
10.1101/2022.11.09.22282122 — Posted: 2022-11-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).